ScreenerHero

CDIOCardio Diagnostics Holdings Inc. Common stock

NAS · US · Healthcare · Biotechnology · cdio.ai
2.030USD+2.01%Mkt Cap: 6.01M $P/E: —

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assess…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap6.01M $
Enterprise Value1.32M $
Revenue (TTM)14.45K $
Gross Profit14.45K $
Net Income (TTM)-6.50M $
Revenue/Share0.0060 USD
Last Price2.030 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.84
PEG—
EV/EBITDA-0.22
EV/Revenue91.59
P/S452.62
P/B0.88
EPS (TTM)-3.16
EPS (Forward)-0.25
52W Range
0.970015% of range7.910
52W High7.910 USD
52W Low0.9700 USD
Profitability
Gross Margin100.00%
Oper. Margin-27950.50%
EBITDA Margin0.00%
Profit Margin-43832.49%
ROE-93.19%
ROA-83.67%
Growth
Revenue Growth-28.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.73M $
CapEx (TTM)419.31K $
FCF Margin-26116.57%
FCF Yield-62.82%
Net Debt-5.22M $
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.10
Current Ratio17.15
Quick Ratio15.56
Book Value/Sh2.509 USD
Cash/Share1.888 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateMay 13, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.96M
Float2.83M
Insiders8.31%
Institutions6.52%
Short Interest
Short Ratio0.3d
Short % Float0.80%
Short % Out.0.80%
Shares Short23.79K
Short (prev mo.)20.24K
Technical
SMA 501.863 (+9.0%)
SMA 2002.379 (-14.7%)
Beta2.22
S&P 52W Chg18.16%
Avg Vol (30d)37.13K
Avg Vol (10d)77.01K
Technical Indicators
RSI (14)59.6
MACD0.0648
MACD Signal0.0214
MACD Hist.+0.0433
BB Upper2.165 USD
BB Middle1.770 USD
BB Lower1.376 USD
BB Width44.58%
ATR (14)0.1756 USD
Vol Ratio (20d)0.82x